Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MFSD14B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | CHAD | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PARP6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | HGFAC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RELT | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CABIN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF497 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | FAM159B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PTTG2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GABPB2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |